Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 03/2/18 → 08/16/21 |
Funding
- IQVIA Incorporated: $14,640.00
Biogen MA: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study in Subjects With Relapsing Multiple Sclerosis to Evaluate the Efficacy and Safety of BIIB033 as an Add-On Therapy to Anti-Inflammatory Disease-Modifying Therapies
- Coyle, Patricia (PI)
- McLinskey, Nancy (CoPI)
- Melville, Patricia (CoPI)
- Syritsyna, Olga (CoPI)
Project: Research